Andrew Hessel

Andrew Hessel is the President of Humane Genomics Inc., a seed-stage company developing synthetic viruses, starting with virus-based therapies for canine cancers. He is a co-founder and Chairman of the Genome Project-write, the international scientific effort working to engineer large genomes, including the human genome. From 2012-2017 Andrew was the Distinguished Researcher at Autodesk Life Sciences. He has been Singularity University faculty since 2009. His goal is to help people better understand and use living systems to meet the needs of society.